• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

CATEGORIES

  • 1

PRICE

0
0
0
1

PUBLISHED

0
0
1
1

PRODUCT TYPE

1

Search "Graft Versus Host Disease (GVHD) Therapeutics - Pipeline Assessment and Market Forecasts to 2018" returned 1 results.

PRODUCT TITLE

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018

OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2018 Summary The main drivers of growth in graft versus host disease over the 2013-2018 forecast period include...

August 2014
FROM
Loading Indicator

Our Clients

Credit Suisse Group Heinz Company Telenor Group Deutsche Bank AG Solvay S.A. APC by Schneider Electric Lindt & Sprüngli AG